Filing excerpt
Operating EBIT was $133 million in the second quarter of 2026, down $19 million from Operating EBIT of $152 million in the second quarter of 2025. Operating EBIT decreased as higher performance-based compensation costs, planned maintenance activity, and fixed costs impacted by the closure of the Barry, U.K., siloxanes plant more than offset higher demand, reduced intangible asset amortization expenses in Consumer Solutions, and the impact of the Company's self-help initiatives.